Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Everolimus Second-Line Treatment in Metastatic or Recurrent Gastric Cancer with pS6 Expression
KCT0000347Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in gastric cancer (GC), sponsored by Novartis. Started Dec 2011; status: completed.
02
Drugs
everolimus
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0000347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000347.